(1)
FOSTAMATINIB AS A NOVEL THERAPEUTIC APPROACH FOR REFRACTORY IMMUNE THROMBOCYTOPENIA IN AN HIV-POSITIVE PATIENT: A CASE REPORT. Eur. J. Emerg. Clin. Case Rep. 2024, 1 (01), 39-45.